Together with her team in Martinsried, Brenda Schulman is investigating one of the most important regulatory mechanisms in the human cell, the ubiquitin system. Disturbances in this complex interplay of multiple proteins can lead to cancer, for example. Schulman received her doctorate at the Massachusetts Institute of Technology (MIT). Before coming to Germany in 2016, she carried out research at the prestigious St. Jude Children’s Research Hospital in Tennessee, among other places.
At the TUM, she will serve as Honorary Professor in the Department of Chemistry. The TUM bestows honorary professorships in order to recruit top minds in research and practice, to help shape its research programs, supervise doctoral thesis and pass the latest knowledge on to students
Protein research as a future-oriented field
“We’re delighted to welcome an outstanding scientist in this immensely important research field to our faculty,” says TUM President Prof. Wolfgang A. Herrmann. Our knowledge of the interplay between various proteins in the human body, he went on to say, is still very incomplete. This research area, which lies at the interface of chemistry, biology, physics and medicine, could be the key to curing many diseases. “The TUM Center for Functional Protein Assemblies, an interdisciplinary research center with a new state-of-the-art laboratory building on the Garching Campus, is currently under construction. Its purpose will be to study the mechanisms of action of proteins with a view to developing biomedical applications,” Herrmann says.
Fruitful cooperation with Max Planck Centers
The TUM has enjoyed a long and productive cooperation with Brenda Schulman’s main workplace, the Max Planck Institute of Biochemistry. Among other things, Nobel laureate Prof. Robert Huber, TUM Alumnus and Emeritus of Excellence, served as the Institute’s Director for many years. In the Max-Planck@TUM alliance young scientists in Martinsried have professorships at TUM. This program is unique in Germany.